Genes with known or likely deleterious variants among cervical cancer patients with DDR gene alterations were ATM (n = 3, 2.33%), BRCA2 (n = 3, 2.33%), ATR (n = 2, 1.55%), CHEK2 (n = 2, 1.55%), followed by BRCA1 (n = 1, 0.78%), FANCA (n = 1, 0.78%), MSH6 (n = 1, 0.78%), and RAD51D (n = 1, 0.78%) (Figure 3C). This evidence concerns the gene CHEK2 and cervical cancer.